nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—CYP3A4—Fingolimod—multiple sclerosis	0.149	0.213	CbGbCtD
Dutasteride—CYP3A4—Methylprednisolone—multiple sclerosis	0.0958	0.137	CbGbCtD
Dutasteride—CYP3A5—Dexamethasone—multiple sclerosis	0.0929	0.133	CbGbCtD
Dutasteride—CYP3A4—Triamcinolone—multiple sclerosis	0.0726	0.104	CbGbCtD
Dutasteride—CYP3A4—Mitoxantrone—multiple sclerosis	0.0699	0.1	CbGbCtD
Dutasteride—CYP3A4—Betamethasone—multiple sclerosis	0.0623	0.0893	CbGbCtD
Dutasteride—CYP3A4—Prednisolone—multiple sclerosis	0.0615	0.0881	CbGbCtD
Dutasteride—CYP3A4—Prednisone—multiple sclerosis	0.058	0.0832	CbGbCtD
Dutasteride—CYP3A4—Dexamethasone—multiple sclerosis	0.0362	0.0519	CbGbCtD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.028	0.123	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.028	0.123	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.028	0.123	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.028	0.123	CbGpPWpGaD
Dutasteride—SRD5A1—Androgen biosynthesis—POMC—multiple sclerosis	0.0152	0.0667	CbGpPWpGaD
Dutasteride—SRD5A2—Androgen biosynthesis—POMC—multiple sclerosis	0.0152	0.0667	CbGpPWpGaD
Dutasteride—Localised oedema—Cladribine—multiple sclerosis	0.00976	0.131	CcSEcCtD
Dutasteride—Depressed mood—Fingolimod—multiple sclerosis	0.00973	0.13	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.0063	0.0277	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.0063	0.0277	CbGpPWpGaD
Dutasteride—CYP3A5—Irinotecan Pathway—BCHE—multiple sclerosis	0.0033	0.0145	CbGpPWpGaD
Dutasteride—Neoplasm malignant—Cladribine—multiple sclerosis	0.00289	0.0387	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00287	0.0126	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00287	0.0126	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00287	0.0126	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00287	0.0126	CbGpPWpGaD
Dutasteride—Depressed mood—Methylprednisolone—multiple sclerosis	0.00273	0.0365	CcSEcCtD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00237	0.0104	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00237	0.0104	CbGpPWpGaD
Dutasteride—Neoplasm malignant—Azathioprine—multiple sclerosis	0.00235	0.0314	CcSEcCtD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00234	0.0103	CbGpPWpGaD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00234	0.0103	CbGpPWpGaD
Dutasteride—Neoplasm—Cladribine—multiple sclerosis	0.00223	0.0298	CcSEcCtD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00192	0.00844	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00192	0.00844	CbGpPWpGaD
Dutasteride—Mental disorder—Fingolimod—multiple sclerosis	0.00191	0.0256	CcSEcCtD
Dutasteride—Cardiac failure—Cladribine—multiple sclerosis	0.00183	0.0246	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—SRM—multiple sclerosis	0.00182	0.00798	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SRM—multiple sclerosis	0.00182	0.00798	CbGpPWpGaD
Dutasteride—Neoplasm—Azathioprine—multiple sclerosis	0.00181	0.0243	CcSEcCtD
Dutasteride—Loss of libido—Methotrexate—multiple sclerosis	0.00175	0.0234	CcSEcCtD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00173	0.00762	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00173	0.00762	CbGpPWpGaD
Dutasteride—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.00153	0.00675	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP24A1—multiple sclerosis	0.00128	0.00562	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP24A1—multiple sclerosis	0.00128	0.00562	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP27B1—multiple sclerosis	0.00128	0.00562	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP27B1—multiple sclerosis	0.00128	0.00562	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00125	0.0055	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00125	0.0055	CbGpPWpGaD
Dutasteride—Cardiac failure—Mitoxantrone—multiple sclerosis	0.00121	0.0161	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—GPC5—multiple sclerosis	0.00117	0.00514	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GPC5—multiple sclerosis	0.00117	0.00514	CbGpPWpGaD
Dutasteride—Immune system disorder—Cladribine—multiple sclerosis	0.00112	0.015	CcSEcCtD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.0011	0.00484	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.0011	0.00484	CbGpPWpGaD
Dutasteride—Pruritus—Fingolimod—multiple sclerosis	0.0011	0.0147	CcSEcCtD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00109	0.00478	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00109	0.00478	CbGpPWpGaD
Dutasteride—Mental disorder—Cladribine—multiple sclerosis	0.00108	0.0145	CcSEcCtD
Dutasteride—Dizziness—Fingolimod—multiple sclerosis	0.00103	0.0137	CcSEcCtD
Dutasteride—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.00102	0.00448	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.00102	0.00448	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00101	0.00442	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00101	0.00442	CbGpPWpGaD
Dutasteride—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000988	0.00434	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—RRM1—multiple sclerosis	0.000969	0.00426	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—RRM1—multiple sclerosis	0.000969	0.00426	CbGpPWpGaD
Dutasteride—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.000936	0.0125	CcSEcCtD
Dutasteride—Immune system disorder—Azathioprine—multiple sclerosis	0.000909	0.0122	CcSEcCtD
Dutasteride—Cardiac failure—Methylprednisolone—multiple sclerosis	0.000907	0.0121	CcSEcCtD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000892	0.00392	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000892	0.00392	CbGpPWpGaD
Dutasteride—Cardiac failure—Dexamethasone—multiple sclerosis	0.000825	0.011	CcSEcCtD
Dutasteride—Cardiac failure—Betamethasone—multiple sclerosis	0.000825	0.011	CcSEcCtD
Dutasteride—Breast disorder—Methylprednisolone—multiple sclerosis	0.0008	0.0107	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000752	0.00331	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000752	0.00331	CbGpPWpGaD
Dutasteride—Neoplasm—Methotrexate—multiple sclerosis	0.00073	0.00977	CcSEcCtD
Dutasteride—Gynaecomastia—Methotrexate—multiple sclerosis	0.000722	0.00967	CcSEcCtD
Dutasteride—Cardiac failure—Prednisone—multiple sclerosis	0.000719	0.00962	CcSEcCtD
Dutasteride—Urticaria—Cladribine—multiple sclerosis	0.000699	0.00936	CcSEcCtD
Dutasteride—Hypersensitivity—Cladribine—multiple sclerosis	0.000648	0.00868	CcSEcCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000646	0.00284	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000646	0.00284	CbGpPWpGaD
Dutasteride—Pruritus—Cladribine—multiple sclerosis	0.000622	0.00833	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000589	0.00259	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000589	0.00259	CbGpPWpGaD
Dutasteride—Dizziness—Cladribine—multiple sclerosis	0.000582	0.00779	CcSEcCtD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000567	0.00249	CbGpPWpGaD
Dutasteride—Erectile dysfunction—Prednisone—multiple sclerosis	0.000558	0.00747	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—BCHE—multiple sclerosis	0.000557	0.00245	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—BCHE—multiple sclerosis	0.000557	0.00245	CbGpPWpGaD
Dutasteride—Rash—Cladribine—multiple sclerosis	0.000555	0.00743	CcSEcCtD
Dutasteride—Dermatitis—Cladribine—multiple sclerosis	0.000554	0.00742	CcSEcCtD
Dutasteride—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000553	0.00741	CcSEcCtD
Dutasteride—Mental disorder—Methylprednisolone—multiple sclerosis	0.000537	0.00719	CcSEcCtD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000533	0.00234	CbGpPWpGaD
Dutasteride—Angioedema—Prednisolone—multiple sclerosis	0.000531	0.00711	CcSEcCtD
Dutasteride—Breast disorder—Methotrexate—multiple sclerosis	0.00053	0.00709	CcSEcCtD
Dutasteride—Hypersensitivity—Azathioprine—multiple sclerosis	0.000527	0.00705	CcSEcCtD
Dutasteride—Angioedema—Triamcinolone—multiple sclerosis	0.000488	0.00654	CcSEcCtD
Dutasteride—Angioedema—Methylprednisolone—multiple sclerosis	0.000487	0.00652	CcSEcCtD
Dutasteride—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000474	0.00208	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000474	0.00208	CbGpPWpGaD
Dutasteride—Dizziness—Azathioprine—multiple sclerosis	0.000473	0.00633	CcSEcCtD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000467	0.00206	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000467	0.00206	CbGpPWpGaD
Dutasteride—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000467	0.00625	CcSEcCtD
Dutasteride—Urticaria—Mitoxantrone—multiple sclerosis	0.000459	0.00615	CcSEcCtD
Dutasteride—Rash—Azathioprine—multiple sclerosis	0.000451	0.00604	CcSEcCtD
Dutasteride—Dermatitis—Azathioprine—multiple sclerosis	0.000451	0.00603	CcSEcCtD
Dutasteride—Angioedema—Betamethasone—multiple sclerosis	0.000443	0.00593	CcSEcCtD
Dutasteride—Angioedema—Dexamethasone—multiple sclerosis	0.000443	0.00593	CcSEcCtD
Dutasteride—Immune system disorder—Prednisone—multiple sclerosis	0.000438	0.00587	CcSEcCtD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000432	0.0019	CbGpPWpGaD
Dutasteride—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000426	0.0057	CcSEcCtD
Dutasteride—Mental disorder—Prednisone—multiple sclerosis	0.000425	0.00569	CcSEcCtD
Dutasteride—Angioedema—Prednisone—multiple sclerosis	0.000386	0.00517	CcSEcCtD
Dutasteride—Urticaria—Prednisolone—multiple sclerosis	0.000377	0.00505	CcSEcCtD
Dutasteride—Immune system disorder—Methotrexate—multiple sclerosis	0.000366	0.0049	CcSEcCtD
Dutasteride—Rash—Mitoxantrone—multiple sclerosis	0.000365	0.00488	CcSEcCtD
Dutasteride—Dermatitis—Mitoxantrone—multiple sclerosis	0.000364	0.00488	CcSEcCtD
Dutasteride—Mental disorder—Methotrexate—multiple sclerosis	0.000355	0.00476	CcSEcCtD
Dutasteride—Hypersensitivity—Prednisolone—multiple sclerosis	0.000349	0.00468	CcSEcCtD
Dutasteride—Urticaria—Triamcinolone—multiple sclerosis	0.000347	0.00464	CcSEcCtD
Dutasteride—Urticaria—Methylprednisolone—multiple sclerosis	0.000346	0.00463	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—APOE—multiple sclerosis	0.000335	0.00147	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—APOE—multiple sclerosis	0.000335	0.00147	CbGpPWpGaD
Dutasteride—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000321	0.0043	CcSEcCtD
Dutasteride—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000321	0.00429	CcSEcCtD
Dutasteride—Urticaria—Dexamethasone—multiple sclerosis	0.000314	0.00421	CcSEcCtD
Dutasteride—Urticaria—Betamethasone—multiple sclerosis	0.000314	0.00421	CcSEcCtD
Dutasteride—Dizziness—Prednisolone—multiple sclerosis	0.000314	0.0042	CcSEcCtD
Dutasteride—Pruritus—Triamcinolone—multiple sclerosis	0.000309	0.00413	CcSEcCtD
Dutasteride—Pruritus—Methylprednisolone—multiple sclerosis	0.000308	0.00412	CcSEcCtD
Dutasteride—Rash—Prednisolone—multiple sclerosis	0.000299	0.004	CcSEcCtD
Dutasteride—Dermatitis—Prednisolone—multiple sclerosis	0.000299	0.004	CcSEcCtD
Dutasteride—Dizziness—Triamcinolone—multiple sclerosis	0.000288	0.00386	CcSEcCtD
Dutasteride—Dizziness—Methylprednisolone—multiple sclerosis	0.000288	0.00385	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—POMC—multiple sclerosis	0.000288	0.00127	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—POMC—multiple sclerosis	0.000288	0.00127	CbGpPWpGaD
Dutasteride—Pruritus—Dexamethasone—multiple sclerosis	0.00028	0.00375	CcSEcCtD
Dutasteride—Pruritus—Betamethasone—multiple sclerosis	0.00028	0.00375	CcSEcCtD
Dutasteride—Rash—Triamcinolone—multiple sclerosis	0.000275	0.00368	CcSEcCtD
Dutasteride—Dermatitis—Triamcinolone—multiple sclerosis	0.000275	0.00368	CcSEcCtD
Dutasteride—Rash—Methylprednisolone—multiple sclerosis	0.000274	0.00367	CcSEcCtD
Dutasteride—Dermatitis—Methylprednisolone—multiple sclerosis	0.000274	0.00367	CcSEcCtD
Dutasteride—Urticaria—Prednisone—multiple sclerosis	0.000274	0.00367	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—ALB—multiple sclerosis	0.000262	0.00115	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ALB—multiple sclerosis	0.000262	0.00115	CbGpPWpGaD
Dutasteride—Dizziness—Betamethasone—multiple sclerosis	0.000262	0.0035	CcSEcCtD
Dutasteride—Dizziness—Dexamethasone—multiple sclerosis	0.000262	0.0035	CcSEcCtD
Dutasteride—Hypersensitivity—Prednisone—multiple sclerosis	0.000254	0.0034	CcSEcCtD
Dutasteride—Rash—Dexamethasone—multiple sclerosis	0.00025	0.00334	CcSEcCtD
Dutasteride—Rash—Betamethasone—multiple sclerosis	0.00025	0.00334	CcSEcCtD
Dutasteride—Dermatitis—Dexamethasone—multiple sclerosis	0.000249	0.00334	CcSEcCtD
Dutasteride—Dermatitis—Betamethasone—multiple sclerosis	0.000249	0.00334	CcSEcCtD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000248	0.00109	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SRM—multiple sclerosis	0.000247	0.00109	CbGpPWpGaD
Dutasteride—Pruritus—Prednisone—multiple sclerosis	0.000244	0.00327	CcSEcCtD
Dutasteride—CYP3A5—Biological oxidations—POMC—multiple sclerosis	0.000229	0.00101	CbGpPWpGaD
Dutasteride—Urticaria—Methotrexate—multiple sclerosis	0.000229	0.00306	CcSEcCtD
Dutasteride—Dizziness—Prednisone—multiple sclerosis	0.000228	0.00305	CcSEcCtD
Dutasteride—Rash—Prednisone—multiple sclerosis	0.000217	0.00291	CcSEcCtD
Dutasteride—Dermatitis—Prednisone—multiple sclerosis	0.000217	0.00291	CcSEcCtD
Dutasteride—Hypersensitivity—Methotrexate—multiple sclerosis	0.000212	0.00284	CcSEcCtD
Dutasteride—Pruritus—Methotrexate—multiple sclerosis	0.000204	0.00273	CcSEcCtD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000201	0.000883	CbGpPWpGaD
Dutasteride—Dizziness—Methotrexate—multiple sclerosis	0.000191	0.00255	CcSEcCtD
Dutasteride—Rash—Methotrexate—multiple sclerosis	0.000182	0.00243	CcSEcCtD
Dutasteride—Dermatitis—Methotrexate—multiple sclerosis	0.000181	0.00243	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	0.000174	0.000767	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	0.000174	0.000767	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GPC5—multiple sclerosis	0.000159	0.000701	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—RRM1—multiple sclerosis	0.000132	0.000581	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SRM—multiple sclerosis	0.000115	0.000506	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—POMC—multiple sclerosis	0.000107	0.000469	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.11e-05	0.000356	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.11e-05	0.000356	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—BCHE—multiple sclerosis	7.59e-05	0.000334	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.41e-05	0.000326	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.14e-05	0.00027	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—APOE—multiple sclerosis	4.57e-05	0.000201	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—POMC—multiple sclerosis	3.92e-05	0.000172	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALB—multiple sclerosis	3.58e-05	0.000157	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.53e-05	0.000155	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—APOE—multiple sclerosis	2.12e-05	9.33e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—POMC—multiple sclerosis	1.82e-05	8.02e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALB—multiple sclerosis	1.66e-05	7.31e-05	CbGpPWpGaD
